India and China push automotive cybersecurity in a new direction

Tern plc

The global automotive industry is undergoing a major shift as cybersecurity moves from a technical afterthought to a regulatory cornerstone. What started in Europe through the UNECE’s WP.29 regulation is now being redefined by the actions of India and China, two markets that are actively advancing global standards.

WP.29 requires manufacturers to integrate Cybersecurity Management Systems and Software Update Management Systems into every stage of the vehicle lifecycle, from design to decommissioning. This regulation makes secure software updates, identity management, and threat monitoring non-negotiable.

India’s vehicle market is growing fast, with connected two-wheelers, electric vehicles, and telematics services gaining traction. But what stands out is the regulatory focus. Indian authorities are demanding strong identity protection across all connected systems, mandatory encryption for updates, and full lifecycle risk analysis.

China has taken a different but equally significant path. Data sovereignty is a central concern, and manufacturers must prove that sensitive vehicle data is stored and processed securely within national boundaries. In addition to meeting core cybersecurity standards, manufacturers must ensure full transparency across their software supply chains and demonstrate control over identity provisioning and update infrastructure.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern cuts H1 loss by 60% as portfolio growth and funding strengthen

Tern reduced its first-half loss by 60%, with net asset value improving and further fundraising strengthening the balance sheet. Additional funding has supported Talking Medicines and Device Authority, while continued progress across the portfolio provides further scope for value creation.

AI control of machines creates a new market for device trust

AI is beginning to control physical machines, increasing demand for technology that can verify device identity before those machines are allowed to act.

Peptide drug development expands beyond GLP-1

GLP-1 success is widening interest in peptide drug development, with the next phase focused on proving clinical value across new therapeutic areas.

Tern Plc announces 90% take-up of Open Offer

Tern Plc has received valid acceptances for 50.9 million Open Offer Shares, representing approximately 90% of the shares available. The fully underwritten offer will raise approximately £509,368 before expenses, with admission of the new shares expected on 24 September 2026.

Talking Medicines moves to capture pharma demand for better patient intelligence

Tighter US pharma advertising rules could increase demand for patient intelligence, supporting the relevance of Talking Medicines’ DrugVoice platform.

Tern portfolio company Talking Medicines launches ‘Intent to Prescribe’ DrugVoice application

Talking Medicines has launched a new DrugVoice application combining its Message Resonance Score™ with near-real-time point-of-care data to help pharmaceutical companies assess links between HCP message alignment and prescribing intent.

Search